Validity of clinical associations of biomarkers in translational research studies: the case of systemic autoimmune diseases - Wikidata - wikimedia - TriplyDB

Validity of clinical associations of biomarkers in translational research studies: the case of systemic autoimmune diseases

Validity of clinical associations of biomarkers in translational research studies: the case of systemic autoimmune diseases

http://www.wikidata.org/entity/Q34346280

about

Current perspectives on systems immunology approaches to rheumatic diseases.Mixing omics: combining genetics and metabolomics to study rheumatic diseases.Advances in systems biology approaches for autoimmune diseases Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures.Validation of new biomarkers in systemic autoimmune diseases Regulatory Forum Opinion Piece*: Veterinary Pathologists in Translational Pharmacology and Biomarker Integration in Drug Discovery and Development.Metabolomics for rheumatic diseases: has the time come?

P2860

Q27687400-BFA80A1C-82DD-46B5-BDF1-1EE4AFEA2023 Q30238656-4E465DF1-3CE2-4CB4-BC9A-61A297FE96F6 Q33619013-847C36E0-BFCA-4955-A46D-7FEA25F10BE7 Q34149941-24788E15-9E70-4A5B-9FB1-5F9E2CD9B99C Q36231859-6FD88DED-17A0-4180-B6C8-10221B9BC82B Q40029271-B6B0C8BB-C2DB-442C-91F0-EBBB8EB25E55 Q54295445-F700D300-A2F8-4854-B1ED-0B25745848B0

P2860

Validity of clinical associations of biomarkers in translational research studies: the case of systemic autoimmune diseases

http://www.wikidata.org/entity/Q34346280

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Validity of clinical associati ...... f systemic autoimmune diseases

@ast

Validity of clinical associati ...... f systemic autoimmune diseases

@en

Validity of clinical associati ...... f systemic autoimmune diseases

@nl

type

label

Validity of clinical associati ...... f systemic autoimmune diseases

@ast

Validity of clinical associati ...... f systemic autoimmune diseases

@en

Validity of clinical associati ...... f systemic autoimmune diseases

@nl

prefLabel

Validity of clinical associati ...... f systemic autoimmune diseases

@ast

Validity of clinical associati ...... f systemic autoimmune diseases

@en

Validity of clinical associati ...... f systemic autoimmune diseases

@nl

P1433

Q34346280-9E05F3B1-8746-40FD-801E-5CE19A4F2DF2

P1476

Q34346280-64204671-A450-44DA-AAD8-561DDCFFA55F

P2093

Q34346280-1BDCD574-220B-4147-9914-85565F4FE950

Q34346280-3AD09652-4B94-4950-A926-E514D7DE01F3

P2860

Q34346280-119B75E1-A201-4F29-888B-C379E7522022

Q34346280-1A6A0062-A906-483E-9592-80D86830A261

Q34346280-1DF5D7B9-F45C-42CB-A9AF-380D82910DBB

Q34346280-20D97B87-CC90-492C-90B0-EC9F124E4F20

Q34346280-2536374C-37A9-4A22-BD76-60240A35FB9B

Q34346280-3D89843D-6496-47BA-9448-7187DBB29AC2

Q34346280-41EF6D7D-BF6C-4F5F-9992-19FE6FC78E89

Q34346280-57F1A695-F931-4DF3-8706-B404E2206DF1

Q34346280-5A707AAB-4D87-4F72-8CE7-7090193059A4

Q34346280-6A7B9D64-1CB3-4505-92A9-A79AD45B4D62

P2888

Q34346280-42CF1461-B851-4BE7-9B5B-9F76E1937667

P304

Q34346280-94D2A44B-6374-4426-9FD3-9E5B0F2B917E

P31

Q34346280-4190C66F-B809-48A4-BE01-6E3E0B11C6E6

P356

Q34346280-78F17BF4-9285-4A8E-B6AA-F7EE76CE0545

P433

Q34346280-C2DCF769-C23B-433A-B9F5-3F8AFC4805B2

P478

Q34346280-E83757E3-EB9E-4E39-943B-C52F104005EA

P577

Q34346280-14D76A21-F9F8-4CF3-9028-C3C51A2DCB9A

P5875

Q34346280-438C4EEA-806E-4DC3-8C8B-AAFC7F2D0F67

P6179

Q34346280-09FF58FC-A2F7-4F35-BB3C-C059892E143F

P698

Q34346280-85E9903E-2EFF-4546-AFD0-3DE63F0F5FC5

P921

Q34346280-7A373C80-7114-4FCD-BDEC-493D0FB32CBC

P932

Q34346280-B23FBE0F-C838-413A-8B1D-4AD65FDE7478

P356

P1433

Arthritis Research and Therapy

P1476

Validity of clinical associati ...... f systemic autoimmune diseases

@en

P2093

Maria G Tektonidou

http://www.w3.org/2001/XMLSchema#string

Michael M Ward

http://www.w3.org/2001/XMLSchema#string

P2860

Expression, modulation and signalling of IL-17 receptor in fibroblast-like synoviocytes of patients with rheumatoid arthritis

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

CXCL16 is a marker of inflammation, atherosclerosis, and acute coronary syndromes in humans

Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus

Problems of spectrum and bias in evaluating the efficacy of diagnostic tests

An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity

Interferon and granulopoiesis signatures in systemic lupus erythematosus blood

Individuality and variation in gene expression patterns in human blood

The cancer biomarker problem.

Biomarkers in systemic lupus erythematosus. I. General overview of biomarkers and their applicability.

P2888

P304

R179

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/AR3143

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46577315

http://www.w3.org/2001/XMLSchema#string

P6179

1015874472

http://www.w3.org/2001/XMLSchema#string

P698

20875104

http://www.w3.org/2001/XMLSchema#string

P921

P932

2991010

http://www.w3.org/2001/XMLSchema#string